I agree that this site is using cookies. You can find further informations here.
X
Loirat, Delphine
140  results:
Search for persons X
?
1

TROPION-Breast03: a randomized phase III global trial of da..:

Bardia, Aditya ; Pusztai, Lajos ; Albain, Kathy...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
2

Tolerance of Concurrent Adjuvant Radiation Therapy and Pemb..:

Tison, Thais ; Loap, Pierre ; Arnaud, Emilie...
Advances in Radiation Oncology.  9 (2024)  3 - p. 101384 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Author Correction: Safety analyses from the phase 3 ASCENT ..:

Rugo, Hope S. ; Tolaney, Sara M. ; Loirat, Delphine...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

Fulvestrant and everolimus efficacy after CDK4/6 inhibitor:..:

Vasseur, Antoine ; Cabel, Luc ; Hego, Caroline...
Oncogene.  43 (2024)  16 - p. 1214-1222 , 2024
Link: https://doi.org/10.1038/..
 
?
5

Veliparib with carboplatin and paclitaxel in BRCA-mutated a..:

Diéras, Véronique ; Han, Hyo S. ; Wildiers, Hans...
European Journal of Cancer.  200 (2024)  - p. 113580 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Sacituzumab govitecan in metastatic triple-negative breast ..:

De Moura, Alexandre ; Loirat, Delphine ; Vaillant, Sarah...
Breast Cancer.  31 (2024)  4 - p. 572-580 , 2024
Link: https://doi.org/10.1007/..
 
?
7

Trastuzumab deruxtecan in previously treated HER2‐positive ..:

Petit, Thierry ; Hajjaji, Nawale ; Antoine, Eric‐Charles...
Cancer Medicine.  13 (2024)  9 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
8

Health-related quality of life in the phase III ASCENT tria..:

Loibl, Sibylle ; Loirat, Delphine ; Tolaney, Sara M....
European Journal of Cancer.  178 (2023)  - p. 23-33 , 2023
Link: https://doi.org/10.1016/..
 
?
9

[18F]FDG PET/CT for predicting triple-negative breast cance..:

Seban, Romain-David ; Arnaud, Emilie ; Loirat, Delphine...
European Journal of Nuclear Medicine and Molecular Imaging.  50 (2023)  13 - p. 4024-4035 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Atezolizumab and paclitaxel as first line therapy in advanc..:

de Moura, Alexandre ; Vuagnat, Perrine ; Renouf, Benjamin...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
11

Paclitaxel plus carboplatin and durvalumab with or without ..:

Buisseret, Laurence ; Loirat, Delphine ; Aftimos, Philippe...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
12

Author Correction: Paclitaxel plus carboplatin and durvalum..:

Buisseret, Laurence ; Loirat, Delphine ; Aftimos, Philippe...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Real-World Impact of Adjuvant Anti-HER2 Treatment on Charac..:

Le Du, Fanny ; Carton, Matthieu ; Bachelot, Thomas...
The Oncologist.  28 (2023)  10 - p. e867-e876 , 2023
Link: https://doi.org/10.1093/..
 
?
14

Overall survival with sacituzumab govitecan in hormone rece..:

Rugo, Hope S ; Bardia, Aditya ; Marmé, Frederik...
The Lancet.  402 (2023)  10411 - p. 1423-1433 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Clinical outcomes of curative-intent multimodal management ..:

Loap, Pierre ; Nicaise, Benjamin ; Laki, Fatima...
Strahlentherapie und Onkologie.  199 (2022)  1 - p. 30-37 , 2022
Link: https://doi.org/10.1007/..
 
1-15